About Ascelia
Ascelia is a company based in Malmo (Sweden) founded in 2000.. Ascelia has raised $6.92 million across 2 funding rounds. Ascelia offers products and services including Orviglance and Oncoral. Ascelia operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Malmo, Sweden
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ascelia Pharma Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.92 M (USD)
in 2 rounds
-
Latest Funding Round
$23.38 M (USD), Post-IPO
Mar 22, 2021
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ascelia
Ascelia offers a comprehensive portfolio of products and services, including Orviglance and Oncoral. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Imaging agent for detecting liver metastases in cancer
Treatment option for gastric cancer patients
Unlock access to complete
Funding Insights of Ascelia
Ascelia has successfully raised a total of $6.92M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $23.38 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $23.4M
-
First Round
First Round
(16 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Post-IPO - Ascelia | Valuation |
investors |
|
| May, 2018 | Amount | Series A - Ascelia | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Ascelia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ascelia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ascelia Comparisons
Competitors of Ascelia
Ascelia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ascelia
Frequently Asked Questions about Ascelia
When was Ascelia founded?
Ascelia was founded in 2000 and raised its 1st funding round 18 years after it was founded.
Where is Ascelia located?
Ascelia is headquartered in Malmo, Sweden.
Is Ascelia a funded company?
Ascelia is a funded company, having raised a total of $6.92M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.92M, raised on May 16, 2018.
What does Ascelia do?
Ascelia was founded in 2000 in Malmo, Sweden, within the pharmaceutical sector. Drug candidates targeting diseases with unmet clinical needs are developed, focusing on orphan indications. Operations center on clinical-stage products, including Mangoral, a contrast agent prepared for phase 3 trials to identify liver metastases via MRI, and Oncoral, an oral chemotherapeutic in phase 2 for advanced gastric cancer.
Who are the top competitors of Ascelia?
Ascelia's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Ascelia offer?
Ascelia offers Orviglance and Oncoral.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.